Search research articles
Contact Us
Filters
Showing results (41-50 of 68) with videos related to
Page
of 7
Sort By:
European Journal of Haematology
|
June 16, 2010
Low-dose rituximab in adult patients with primary immune thrombocytopenia
Francesco Zaja, Nicola Vianelli, Stefano Volpetti, et al.
Cancer
|
April 21, 2012
Evaluation of residual CD34(+) Ph(+) progenitor cells in chronic myeloid leukemia patients who have complete cytogenetic response during first-line nilotinib therapy
Marzia Defina, Micaela Ippoliti, Alessandro Gozzetti, et al.
Oncotarget
|
August 17, 2016
Genetic predisposition and induced pro-inflammatory/pro-oxidative status may play a role in increased atherothrombotic events in nilotinib treated chronic myeloid leukemia patients
Monica Bocchia, Sara Galimberti, Lara Aprile, et al.
Pharmacogenomics and Personalized Medicine
|
May 2, 2022
Therapeutic Management of Patients with FLT3 + Acute Myeloid Leukemia: Case Reports and Focus on Gilteritinib Monotherapy
Monica Bocchia, Angelo Michele Carella, Antonino Mulè, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 19, 2013
Prospective phase II Study on 5-days azacitidine for treatment of symptomatic and/or erythropoietin unresponsive patients with low/INT-1-risk myelodysplastic syndromes
Carla Filì, Michele Malagola, Matilde Y Follo, et al.
Frontiers in Pharmacology
|
June 12, 2023
Prospective monitoring of chronic myeloid leukemia patients from the time of TKI discontinuation: the fate of peripheral blood CD26<sup>+</sup> leukemia stem cells
Paola Pacelli, Adele Santoni, Anna Sicuranza, et al.
Haematologica
|
April 12, 2008
Lower dose rituximab is active in adults patients with idiopathic thrombocytopenic purpura
Francesco Zaja, Marta Lisa Battista, Maria Teresa Pirrotta, et al.
Annals of Hematology
|
March 24, 2023
Multicenter retrospective analysis of clinical outcome of adult patients with mixed-phenotype acute leukemia treated with acute myeloid leukemia-like or acute lymphoblastic leukemia-like chemotherapy and impact of allogeneic stem cell transplantation: a Campus ALL study
Davide Lazzarotto, Ilaria Tanasi, Antonella Vitale, et al.
Leukemia Research
|
September 26, 2022
Levocarnitine supplementation for asparaginase-induced hepatotoxicity in adult acute lymphoblastic leukemia patients: A multicenter observational study of the campus all group
Marzia Defina, Davide Lazzarotto, Fabio Guolo, et al.
Haematologica
|
August 1, 2024
Ponatinib alone or with chemo-immunotherapy in heavily pre treated Philadelphia-like acute lymphoblastic leukemia: a CAMPUS ALL real-life study
Francesca Kaiser, Monia Lunghi, Deborah Cardinali, et al.
Page
of 7
Search research articles
Search
Showing results (41-50 of 68) with videos related to
Sort By:
Page
of 7
European Journal of Haematology
|
June 16, 2010
Low-dose rituximab in adult patients with primary immune thrombocytopenia
Francesco Zaja, Nicola Vianelli, Stefano Volpetti, et al.
Cancer
|
April 21, 2012
Evaluation of residual CD34(+) Ph(+) progenitor cells in chronic myeloid leukemia patients who have complete cytogenetic response during first-line nilotinib therapy
Marzia Defina, Micaela Ippoliti, Alessandro Gozzetti, et al.
Oncotarget
|
August 17, 2016
Genetic predisposition and induced pro-inflammatory/pro-oxidative status may play a role in increased atherothrombotic events in nilotinib treated chronic myeloid leukemia patients
Monica Bocchia, Sara Galimberti, Lara Aprile, et al.
Pharmacogenomics and Personalized Medicine
|
May 2, 2022
Therapeutic Management of Patients with FLT3 + Acute Myeloid Leukemia: Case Reports and Focus on Gilteritinib Monotherapy
Monica Bocchia, Angelo Michele Carella, Antonino Mulè, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 19, 2013
Prospective phase II Study on 5-days azacitidine for treatment of symptomatic and/or erythropoietin unresponsive patients with low/INT-1-risk myelodysplastic syndromes
Carla Filì, Michele Malagola, Matilde Y Follo, et al.
Frontiers in Pharmacology
|
June 12, 2023
Prospective monitoring of chronic myeloid leukemia patients from the time of TKI discontinuation: the fate of peripheral blood CD26<sup>+</sup> leukemia stem cells
Paola Pacelli, Adele Santoni, Anna Sicuranza, et al.
Haematologica
|
April 12, 2008
Lower dose rituximab is active in adults patients with idiopathic thrombocytopenic purpura
Francesco Zaja, Marta Lisa Battista, Maria Teresa Pirrotta, et al.
Annals of Hematology
|
March 24, 2023
Multicenter retrospective analysis of clinical outcome of adult patients with mixed-phenotype acute leukemia treated with acute myeloid leukemia-like or acute lymphoblastic leukemia-like chemotherapy and impact of allogeneic stem cell transplantation: a Campus ALL study
Davide Lazzarotto, Ilaria Tanasi, Antonella Vitale, et al.
Leukemia Research
|
September 26, 2022
Levocarnitine supplementation for asparaginase-induced hepatotoxicity in adult acute lymphoblastic leukemia patients: A multicenter observational study of the campus all group
Marzia Defina, Davide Lazzarotto, Fabio Guolo, et al.
Haematologica
|
August 1, 2024
Ponatinib alone or with chemo-immunotherapy in heavily pre treated Philadelphia-like acute lymphoblastic leukemia: a CAMPUS ALL real-life study
Francesca Kaiser, Monia Lunghi, Deborah Cardinali, et al.
Page
of 7